Background-Fetal hypoxia has been implicated in the abnormal brain development seen in newborns with congenital heart disease (CHD). New magnetic resonance imaging technology now offers the potential to investigate the relationship between fetal hemodynamics and brain dysmaturation. Methods and Results-We measured fetal brain size, oxygen saturation, and blood flow in the major vessels of the fetal circulation in 30 late-gestation fetuses with CHD and 30 normal controls using phase-contrast magnetic resonance imaging and T2 mapping. Fetal hemodynamic parameters were calculated from a combination of magnetic resonance imaging flow and oximetry data and fetal hemoglobin concentrations estimated from population averages. In fetuses with CHD, reductions in umbilical vein oxygen content (P<0.001) and failure of the normal streaming of oxygenated blood from the placenta to the ascending aorta were associated with a mean reduction in ascending aortic saturation of 10% (P<0.001), whereas cerebral blood flow and cerebral oxygen extraction were no different from those in controls. This accounted for the mean 15% reduction in cerebral oxygen delivery (P=0.08) and 32% reduction cerebral Vo 2 in CHD fetuses (P<0.001), which were associated with a 13% reduction in fetal brain volume (P<0.001). Fetal brain size correlated with ascending aortic oxygen saturation and cerebral Vo 2 (r=0.37, P=0.004). Conclusions-This study supports a direct link between reduced cerebral oxygenation and impaired brain growth in fetuses with CHD and raises the possibility that in utero brain development could be improved with maternal oxygen therapy.
T he neurodevelopmental outcomes of children with congenital heart disease (CHD) remain a cause for concern. Although a proportion of this morbidity is attributable to injury occurring in the perioperative period, there is increasing evidence that CHD is associated with fetal brain dysmaturation. 1, 2 A reduction in brain growth and maturation during the third trimester has been demonstrated in fetuses with CHD through the use of magnetic resonance imaging (MRI) brain volumetry and magnetic resonance spectroscopy, 1 whereas term newborns with transposition of the great arteries (TGA) or with single-ventricle (SV) physiology display microstructural and metabolic brain parameters more in keeping with premature infants than normal controls. 2 Furthermore, recent evidence suggests that this brain dysmaturation is associated with increased vulnerability to white matter injury around neonatal cardiac surgery and decrements in neurodevelopmental outcome at 2 years. 3, 4 Reductions in middle cerebral artery pulsatility measured by transcranial ultrasound have been observed in fetuses with CHD, raising the possibility of cerebral vasodilation in response to hypoxia, 5 and fetal cerebral and placental Doppler indexes have recently been linked to developmental outcome in CHD. 6 Advances in MRI technology have provided a new approach to evaluating fetal hemodynamics. 7 In the present study, we sought to investigate the relationship between fetal hemodynamics and brain growth in fetuses with CHD compared with normal controls using MRI.
Methods
The study design is a prospective, observational, cross-sectional, case-control study comparing fetal hemodynamic parameters and brain size measured by MRI in fetuses with and without CHD. A sample size of 30 cases and 30 controls was determined from the resources available for the study.
Study Participants
The research ethics board of the Hospital for Sick Children approved the study, and written consent was obtained from every mother before study enrollment. We recruited study subjects from the Fetal Cardiac Program at the Hospital for Sick Children and controls from the lowrisk outpatient clinic at Mount Sinai Hospital in Toronto during a 1-year period from May 2013 to May 2014. Consecutive patients with CHD severe enough to warrant a period of inpatient monitoring or neonatal cardiac surgery or intervention after birth were invited to participate in the study. Exclusion criteria in both cohorts included significant maternal medical problems, including pregnancy-induced hypertension, diabetes mellitus, and autoimmune disease, and fetal conditions such as intrauterine growth restriction and anemia. Fetuses with prenatally diagnosed congenital malformations and genetic syndromes were also excluded. The CHD group underwent detailed diagnostic fetal echocardiography in the second trimester according to published guidelines. 8 
MRI Protocol
The same imaging protocol was used for each subject and consisted of a fetal MRI scan during the final weeks of pregnancy. The scans were performed on a clinical 1.5-T MRI system (Siemens Avanto, Erlangen, Germany) without sedation.
Blood Flow Quantification
Vessel flow was quantified using cine phase-contrast measurements in each of the major fetal vessels and indexed to the fetal weight according to our previously published technique. 
Fetal Brain Volumetry
The 3-dimensional steady-state free-precession acquisition used to measure fetal volume was also used to measure fetal brain volume, which we converted to estimated fetal brain weight using a published conversion factor based on fetal brain density. 10 The imaging parameters for this acquisition, which was acquired during a single maternal breath hold, are as follows: echo time, 1.74 milliseconds; repetition time, 3.99 milliseconds; slice thickness, 2 mm; matrix size, 256×205×80; field of view, 400 mm; signal average, 1; parallel imaging factor, 2; and average scan time, 13 seconds. Postprocessing of the acquisition to segment the fetal brain was performed by use of a combination of threshold, cutting, and filling tools with a commercial software package (Mimics, Materialize, Leuven). An example of fetal brain segmentation is shown in Figure 1 . We converted the fetal brain weights to gestational age-appropriate Z scores according to a previously published large autopsy series.
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Magnetic Resonance Oximetry
The T2 relaxation of any tissue is a time constant derived from the exponential rate of decay of its MRI signal. The almost linear relationship between the oxygen saturation of blood and its T2 relaxation results from the proportions of diamagnetic oxygenated hemoglobin and paramagnetic deoxygenated hemoglobin. Wright et al 12 defined this relationship as follows:
where T2o is the T2 of fully oxygenated blood for a given hemoglobin concentration and K is a constant that depends on the magnetic field strength and the refocusing interval of the T2 preparation pulse of the imaging sequence used to measure T2. T2 mapping is the technique used to measure the T2 of a tissue and consists of the acquisition of a series of images with different T2 preparation times, which allow T2 curves to be calculated for each voxel and displayed as a T2 map. The T2 of blood in a vessel is measured by placing a region of interest in the center of the vessel. Spatial resolution criteria for ensuring accurate vessel T2 quantification by avoiding contamination of the signal from blood by surrounding tissues have been established. 13 According to this work, the region of interest should be <60% of the vessel diameter and a minimum of 6 pixels across the vessel diameter with a slice thickness less than the vessel. The importance of prescribing the imaging plane perpendicular to the long axis of the vessel to avoid partial volume artifacts is also emphasized.
The imaging technique we used for T2 mapping in this study was adapted from a new sequence designed for myocardial T2 mapping that uses a T2 preparation pulse followed by a rapid steady-state free-precession readout with an echo time of 1.15 milliseconds and repetition time of 3.97 milliseconds. 7, 14, 15 An interval of 4 seconds between the individual T2 preparation images was used to ensure adequate magnetization recovery, and 5 T2 preparation images with T2 prep times spread evenly across the expected T2 of the vessel were obtained for each T2 map. We used a slice thickness of 5 mm, a matrix size of 224×181, and a field of view of 300 mm with 1 signal average and a parallel imaging factor of 2, resulting in a scan time of 16 seconds and in-plane spatial resolution of 1.3 mm. The diameter of the umbilical vein (UV), descending aorta, main pulmonary artery, and ascending aorta (AAo) are all in excess of 7 mm at term, thus ensuring a minimum of 6 pixels across the vessel diameter. 16 Only the superior vena cava (SVC), which has a diameter of ≈5 mm toward term, results in imaging with less than the recommended spatial resolution. A critically important innovation with regard to fetal T2 mapping that is incorporated into the sequence we used is its nonrigid Figure 1 . Fetal brain volumetry in a normal term fetus by magnetic resonance imaging using segmentation of a 3-dimensional steady-state free-precession acquisition. by guest on August 31, 2017 http://circ.ahajournals.org/ Downloaded from registration motion correction algorithm, which corrects for small fetal and maternal movements occurring between each T2 preparation image. When more gross fetal motions resulted in more significant artifact, the sequence was repeated, a situation that occurred in ≈25% of the measurements. Examples of T2 maps of the umbilical cord and mediastinal 3-vessel view are shown in Figure 2 .
Hemodynamic Calculations
We used the phase-contrast and T2 measurements to calculate fetal oxygen delivery (Do 2 ) and consumption (Vo 2 ) and fetal cerebral Do 2 and Vo 2 . The fetal and fetal cerebral oxygen extraction fractions (OEFs) were calculated as fetal Vo 2 /Do 2 and cerebral Vo 2 /Do 2 , respectively. The oxygen content of the blood was estimated from the T2 measurements and gestational age-appropriate population averages for blood hemoglobin concentration. 17 Because the T2o of human fetal blood is not known, we used the previously established value of 250 milliseconds for the T2o of adult blood. 12 Fetal Do 2 was calculated as the product of UV flow and UV O 2 content, whereas fetal Vo 2 was obtained from the product of UV flow and the difference between the UV and artery O 2 content. 18 Because of the small size of the umbilical arteries, their O 2 content was estimated from the T2 measurement made in the descending aorta at the diaphragm, which directly supplies them. The small size of the vessels exclusively supplying and draining the brain also makes them unsuitable for accurate phase-contrast MRI and T2 mapping. However, cerebral blood flow accounts for the majority of venous drainage to the SVC in children, so we used SVC flow and T2 values of the aortic arch and SVC to approximate cerebral Do 2 and cerebral Vo 2 . 19 The blood hemoglobin concentration was measured in the fetuses with CHD on the first day of life as part of a complete blood count. Hemoglobin concentration was not measured in the control group.
Clinical Assessment and Follow-Up
A chart review was performed for each patient at the end of the study period, which resulted in a period of follow-up of between 1 and 12 months. All newborns with antenatally diagnosed CHD underwent neonatal echocardiograms to confirm the cardiac diagnosis. The diagnosis of any associated congenital abnormality or genetic syndrome was recorded. Those infants with CHD associated with dysmorphic features or additional lesions underwent microarray genetic testing. The approach to managing the CHD was noted, as were the overall outcomes at follow-up in terms of mortality and morbidity.
Statistical Analysis
The initial analysis comprised a comparison between fetal hemodynamic parameters and brain size in normal fetuses compared with fetuses with CHD. We then compared the same parameters in subgroups of fetuses with CHD against controls, with subgroups defined as those with SV versus biventricular hearts and those with the 2 most commonly encountered individual cardiac lesions, TGA and tetralogy of Fallot (TOF). Finally, we correlated specific hemodynamic parameters with fetal brain size. Fetal brain size, Do 2 , OEF, Vo 2 and cerebral Do 2 , and OEF and Vo 2 were all confirmed to be normally distributed by use of the Kolmogorov-Smirnov test in the fetuses with CHD and controls. A Student t test was used to compare variables between controls and fetuses with CHD, and a 1-way ANOVA with a Dunnett multiple-comparison test was used to compare the variables between the control group and subgroups of CHD. A Mann-Whitney test was used to compare variables in fetuses with and without genetic syndromes. The Pearson correlation was used to examine the relationships between the listed variables. Interobserver agreement for the phase-contrast and T2 measurements was compared by use of the Pearson correlation and Bland-Altman plots. Values of P<0.05 were considered statistically significant. Statistical analysis was performed with GraphPad Prism 6.0e.
Results
A complete set of individual measured and calculated variables is given in the online-only Data Supplement. We enrolled 30 cases with CHD and 30 controls and performed fetal cardiovascular MRI at a mean gestational age of 36 weeks (SD, 1.0 week). There was no significant difference in gestational age between the normal and CHD groups (P=0.5). There were 8 fetuses with SV hearts and 22 fetuses with biventricular hearts, of which 7 had TGA and 7 had TOF. Table 1 shows the demographic details of the CHD study subjects, including their cardiac diagnosis, associated congenital abnormalities, genetic diagnoses, the type of surgery they underwent, and their clinical status at the completion of the study period. Figure 3 shows the high level of agreement and lack of bias between 2 observers for fetal vessel blood flow and T2 measurements (r=0.97, P=0.0001). The mean hemoglobin concentration on the first day of life in the newborns with CHD was 16.3 g/dL with a range of 13.0 to 19.4 g/dL, which is similar to published reference ranges (mean, 17 g/dL; range, 14-20 g/dL). 20 Table 2 shows measured and calculated variables for normal fetuses and fetuses with CHD, and Table 3 shows a comparison of these variables between controls and individual subgroups of CHD. The results are also illustrated in Figures 4 through 6 .
When the fetuses with CHD were collectively compared with controls, we found a mean 10% reduction in the oxygen saturation (Sao 2 ) of blood supplied to the developing brain (P<0.0001). Because there was no difference in cerebral blood flow (SVC flow, P=0.6), this resulted in an almost statistically significant 15% reduction in cerebral Do 2 (P=0.08). Because there was no difference in the extraction of oxygen by the brain (P=0.5), the result was a mean 32% reduction in cerebral Vo 2 in fetuses with CHD (P<0.001). This was associated with a mean 13% reduction in brain volume (P<0.001) or a full 1-SD reduction in estimated brain weight Z score (P<0.001). We found a mean 6% reduction in UV Sao 2 (P=0.0004), which was associated with a mean 17% reduction in fetal Do 2. In normal controls, the mean AAo Sao 2 was 7% higher than in the main pulmonary artery, whereas in fetuses with CHD, the 
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mean AAo Sao 2 was only 2% higher than the main pulmonary artery Sao 2 , so streaming was responsible for a significant increase in AAo Sao 2 compared with main pulmonary artery Sao 2 in controls but not in fetuses with CHD (P=0.03). There was a 30% reduction in CVO in fetuses with an SV compared with those with biventricular CHD (P=0.003), and this was associated with a 20% reduction in UV flow (P=0.002). UV flow correlated with CVO across the whole study group (r=0.27, P=0.03), as shown in Figure 4 . The combination of lower UV Sao 2 and lower UV flow in fetuses with CHD as a whole resulted in a 17% reduction in Do 2 (P=0.006), which was associated with a 17% reduction in fetal Vo 2 (P=0.007). Fetal Do 2 was further reduced in fetuses with an SV compared with fetuses with biventricular CHD (P=0.0.03), and fetuses with an SV also had the lowest AAo Sao 2 , although AAo Sao 2 was significantly lower than in controls for all of the subgroups of CHD except TOF (P=0.0001). Cerebral Vo 2 was lower in all subgroups of CHD than in controls except the SV group (P=0.0001), whereas brain volume was lower than in controls in all CHD subgroups except fetuses with TGA and an SV (P=0.0001). There were no significant differences between subgroups of CHD and controls in terms of SVC AS indicates aortic stenosis; ASO, arterial switch operation; AVSD, atrioventricular septal defect; BAV, bicuspid aortic valve; BCPS, bidirectional cavopulmonary shunt; CC, corpus callosum; CHD, congenital heart disease; CoA, aortic coarctation; DORV, double-outlet right ventricle; HLHS, hypoplastic left heart syndrome; IAA, interrupted aortic arch; MAPCA, major aortopulmonary collateral artery; MS, mitral stenosis; PA, pulmonary atresia; PAB, pulmonary artery band; PL, pulmonary lymphangectasia; PPM, permanent pacemaker; TAPVC, totally anomalous pulmonary venous connection; TEF, trachea-esophageal fistula; TGA, transposition of the great arteries; TOF, tetralogy of Fallot; TR, tricuspid regurgitation; VA, ventriculoarterial; and VSD, ventricular septal defect.
by guest on August 31, 2017 http://circ.ahajournals.org/ Downloaded from flow, cerebral Do 2 , cerebral OEF, or OEF. There were no significant differences between the 3 syndromic and 27 nonsyndromic fetuses with CHD in terms of brain volume (P=0.9) or cerebral Vo 2 (P=0.7).
We found no relationship between fetal Vo 2 and fetal cerebral Vo 2 (P=0.62) and no correlation between CVO and SVC flow for the whole cohort or for any individual group. SVC flow comprised 30% of the CVO in controls and 31% of the CVO in fetuses with CHD, and there was no significant difference between the proportion of the CVO devoted to cerebral perfusion in any of the subgroups of CHD (P=0.17). There were significant correlations between both AAo Sao 2 (r=0.33, P=0.01) and fetal cerebral Vo 2 (r=0.37, P=0.004) and estimated fetal brain weight Z score across the whole study population, as shown in Figure 7 . However, the correlations between AAo Sao 2 , fetal cerebral Vo 2 , and brain volume were not statistically significant.
Discussion Fetal Cerebral Oxygenation and Brain Growth and Development
The abnormal connections and obstructions of flow present in fetuses with CHD have long been suspected of causing a reduction in the nutritional content and oxygen saturation of blood supplied to the developing fetal brain. 18 Reductions in middle cerebral artery pulsatility index found in CHD 5 are in keeping with the "brain-sparing physiology" seen in animals exposed to acute hypoxia and human pregnancies affected by placental insufficiency. 18, 21 However, fetal animal models suggest that after prolonged periods of hypoxia, cerebral vascular tone tends to normalize, with downregulation of neuronal and glial metabolism that results in reduced cerebral Vo 2 and associated changes in brain growth and development. 22 In our study, the mean SVC flow was the same in each of the groups despite the lower oxygen content of the blood supplied to the brain in fetuses with CHD. Our findings would therefore be more in keeping with a model of reduced cerebral Vo 2 resulting from chronic hypoxia than the brain-sparing physiology seen in acute fetal hypoxia. An alternative explanation of our findings is that fetal cerebral Vo 2 is reduced in fetuses with CHD for some other reason than reduced cerebral Do 2 that was not captured by our study. The fact that the mean 15% reduction in cerebral Do 2 we found in fetuses with CHD did not reach statistical significance while the reduction in cerebral Vo 2 was highly significant would be in keeping with additional factors affecting fetal brain metabolism and growth than simply cerebral Do 2 . However, the lack of difference between the syndromic and nonsyndromic fetuses with CHD in terms of brain size and cerebral Vo 2 would suggest that, in this cohort at least, genetic diagnoses were not responsible for the abnormal cerebral hemodynamics and brain growth we found in the CHD group. At least 3 circulatory mechanisms appear to be affecting the oxygen content of blood supplied to the brain in fetuses with CHD. Figure 8 shows the oxygen saturations across the circulations of representative examples of a normal fetus and fetuses with hypoplastic left heart syndrome, TGA, and TOF by MRI. In the normal fetal circulation, there is streaming of oxygenated blood from the placenta to the fetal cerebral circulation via the ductus venosus and foramen ovale. In each of the examples of CHD, this pathway is disrupted. In TGA, streaming results in welloxygenated blood being directed to the pulmonary circulation, whereas the blood supplied to brain is derived largely from more deoxygenated blood returning from the caval veins. In TOF, the oxygenated blood crossing the foramen ovale passes into the aorta in the normal way but is diluted by more deoxygenated blood shunting from right to left across the ventricular septal defect. In hypoplastic left heart syndrome, no streaming of oxygenated blood is possible because there is essentially only 1 outlet of the heart, so the entire fetal circulation is supplied by blood with the same oxygen content. In addition to the disruption of streaming of oxygenated blood toward the brain, in SV hearts, oxygen delivery to the fetus as a whole is affected by a reduction in combined ventricular output. Fetal animal models indicate that the principal determinant of placental blood flow is fetal blood pressure and that blood pressure is dependent on cardiac output. 18 We conclude that the lack of 2 functioning ventricles is the driver behind the reductions in UV flow and the resulting drop in fetal Do 2 in SV hearts. The impact of ventricular hypoplasia on CVO is likely to be further compounded by the presence of atrioventricular valve regurgitation. In our study, there were 2 fetuses with an SV with significant atrioventricular valve regurgitation, and the mean CVO was 25% lower in these fetuses than fetuses with an SV without regurgitation. This was not statistically significant, likely because of the small sample size. Finally, a third factor contributing to lower oxygen saturations in fetuses with CHD was the reduction in UV Sao 2 , which is suggestive of abnormal placental function and results in lower fetal Do 2 even in the setting of normal CVO and UV flow. This interpretation is supported by the high incidence of placental abnormalities found in the setting of CHD on gross pathology and histopathology. 23 The reason for the higher cerebral Vo 2 we observed in fetuses with SV hearts than in fetuses with biventricular hearts is not certain, and we suspect this is a spurious result resulting from our small sample size. Indeed, the small size of the subgroups of CHD in general means that caution should be exercised in the interpretation of differences between these groups and that further studies with larger sample sizes are necessary to convincingly characterize the fetal hemodynamics of each subtype of CHD.
Our demonstration of reduced fetal brain size in third-trimester fetuses with CHD is in keeping with a previous study that also demonstrated changes in fetal brain metabolism using magnetic resonance spectroscopy that were attributed to reduced cerebral Do 2 .
1 Because brain dysmaturation appears to confer increased susceptibility to white matter injury in the perioperative period and neurodevelopmental deficits at 2 years, the identification of fetal hypoxia as a potentially modifiable cause of delayed fetal brain development may be clinically significant. 3, 4 For example, previous authors have shown that oxygen saturations in the fetal sheep circulation can be augmented through increases in the oxygen concentration of maternal inhaled air. 18 This also appears to be the case in healthy humans, in whom maternal hyperoxygenation results in oxygen-mediated pulmonary vasodilation. 24 Although fetal brain volumetry by MRI provides a ready marker of fetal brain growth, it is a crude tool compared with the array of measures of brain maturation now available with neonatal brain MRI. Further investigation of the relationship between fetal hemodynamics and brain development should Furthermore, a single late-gestation fetal hemodynamic assessment is not likely to capture a comprehensive picture of how hemodynamics affect brain development throughout the prenatal period, and in the future, it will be important to develop new techniques to allow a similar approach to be applied earlier in the pregnancy so that serial measurements can be performed.
Discussion of Methodology
The techniques used to obtain the results reported in this study are not well established, and a discussion of their validity is warranted. Phase-contrast MRI is widely used in the noninvasive quantification of vessel flow in postnatal subjects and is more accurate than ultrasound. 25 We have validated this technique in human fetuses and published reference values for the distribution of blood flow in the normal late-gestation human fetus. 9 MR oximetry using quantitative T2 mapping of blood was developed by Wright et al 12 and initially reported in 1991. We have since shown the fidelity of magnetic resonance oximetry compared with conventional blood gases in children with CHD, 26 and Wedegärtner et al 27 showed that T2 fetal MRI oximetry was feasible in the cardiac ventricles of fetal lambs. The magnetic properties of human fetal blood have not been determined, and further validation work to establish the exact relationship between T2 and Sao 2 in blood that contains a high proportion of the fetal form of hemoglobin is warranted. However, although any inaccuracy of our technique introduced by differences in the magnetic properties of fetal and adult blood might affect our absolute Sao 2 values, it would not be expected to have a major impact on the comparison of normal and CHD fetuses. The conversion of T2 to Sao 2 also depends on the hemoglobin concentration of blood, and unfortunately, there is currently no way to measure hemoglobin concentration noninvasively in the fetus. Our approach to this problem was to estimate the fetal hemoglobin concentration on the basis of population averages, which have been more thoroughly characterized in the late second trimester than in the third trimester, and the lack of convincing data for the normal fetal hemoglobin concentration of late gestation fetuses is an important potential source of inaccuracy in our study. However, we suspect that such variations will cancel out when the results of a large sample are combined. The agreement between our technique and estimations of the distribution of blood flow, Sao 2 , Do 2 , and Vo 2 in the normal human fetal circulation with those made with invasive techniques in fetal lambs and cordocentesis measurements made in human fetuses supports the accuracy of our technique. 18, 28 The application of normal ranges for estimating hemoglobin concentration to fetuses with CHD is also problematic. There are no published ranges for fetal hemoglobin in fetuses with CHD, although previous studies have shown that hematologic indexes in newborns with CHD are within the normal range. 29 However, chronic hypoxia leads to fetal polycythemia, with increases in hemoglobin concentration in the 20% range seen in fetuses with significant placental insufficiency. 30 Polycythemia results in a reduction in the T2 of blood owing to an increase in paramagnetic deoxyhemoglobin. 12 If the fetuses with CHD in our study were polycythemic because of chronic in utero hypoxia, this could have exaggerated the reductions in Do 2 we found. However, inaccuracies in the estimation of hemoglobin concentration would have a negligible effect on measurements of Vo 2 because Vo 2 is determined primarily by flow and the difference in T2. Furthermore, in our study, the mean hemoglobin concentration of the newborns with CHD was just below the normal mean, with nearly all of the measurements falling within the normal range, and we conclude that the hemoglobin concentration in these fetuses was not responsible for the reductions we found in vessel T2s. In the future, it may be possible to improve the accuracy of fetal MR oximetry with the addition of T1 mapping to measure the hemoglobin concentration of fetal blood because a strong relationship exists between T1 and hematocrit. 31 Additional concerns about the accuracy of fetal vessel oximetry based on T2 quantification arise from the small size of the vessels of interest. In particular, the SVC measurements could be subject to partial volume artifacts, which would affect the accuracy of cerebral Vo 2 quantification and therefore the whole basis of our analysis. However, if partial volume artifacts were significantly affecting the SVC T2, the high T2 of adjacent lung might be expected to result in erroneously high T2 values, whereas in practice, the SVC T2 values we obtained with T2 mapping were consistently the lowest in the fetal circulation. Nevertheless, additional validation of the present approach to fetal oximetry in small vessels is warranted. Future advances in MRI technology are likely to improve the accuracy of fetal MR oximetry in the future. For example, in another approach to reducing partial volume artifacts called T2 relaxation under spin tagging, the blood is labeled so that its signal can be better discriminated from the surrounding tissues. 32 Our conversion of fetal brain volume to fetal brain weight and estimation of fetal brain weight Z score from autopsy normal ranges was an attempt to correct this measure of brain growth for variation in gestational age across the study cohort. Although we recognize that ideally we would have performed this analysis using Z scores for fetal brain volume, these are currently not available. The technique we used for fetal brain volumetry comprises segmentation of a high-resolution 3-dimensional steady-state free-precession acquisition. This sequence has been used to good effect for fetal volumetry and for making 3-dimensional fetal models and is equally well suited to performing volumetry of the fetal brain. 9, 33 Its advantages over conventional single-shot fast-spin-echo techniques include its 3-dimensional nature, the high contrast between the bright cerebrospinal fluid and dark brain parenchyma, and the shorter scan time, which allows the whole acquisition to be acquired during a single maternal breath hold. Because
